A Phase IB Study of Sorafenib for Patient With Locally Advanced or Metastatic Hepatocellular Carcinoma and Child's B Cirrhosis.
Phase of Trial: Phase I
Latest Information Update: 22 May 2012
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Pharmacokinetics
- 10 Jun 2017 Biomarkers information updated
- 22 May 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 30 Nov 2010 Planned end date changed from 1 Sep 2010 to 1 Nov 2010 as reported by ClinicalTrials.gov